Figure 3
Figure 3. CYT107 induces the expansion of effector memory CD4+ and CD8+ T cells but no changes in Treg or CD127 expression. (A) CYT107 predominantly induces an expansion of effector memory T cells with an increase in naive CD4+ and CD8+ T cells in a minority of patients. Each panel represents absolute values of T-cell subsets of CD4+ or CD8+ T cells using CD45RA and CCR7 expression to distinguish naive (CD45RA+CCR7+), central memory (CD45RA−CCR7+), effector memory (CD45RA−CCR7−), and effector (CD45RA+CCR7−) T cells. Data for individual patients are shown. (B) CYT107 administration does not affect the relative frequency of Tregs, defined as CD4+CD25hiFoxP3+ T cells. Left: Absolute Treg counts for individual patients. Right: Mean ratio Treg count/baseline ± SEM for each cohort. (C) CYT107 administration does not affect long-term expression of CD127 on CD4+ or CD8+ T cells (data for individual patients shown).

CYT107 induces the expansion of effector memory CD4+ and CD8+ T cells but no changes in Treg or CD127 expression. (A) CYT107 predominantly induces an expansion of effector memory T cells with an increase in naive CD4+ and CD8+ T cells in a minority of patients. Each panel represents absolute values of T-cell subsets of CD4+ or CD8+ T cells using CD45RA and CCR7 expression to distinguish naive (CD45RA+CCR7+), central memory (CD45RACCR7+), effector memory (CD45RACCR7), and effector (CD45RA+CCR7) T cells. Data for individual patients are shown. (B) CYT107 administration does not affect the relative frequency of Tregs, defined as CD4+CD25hiFoxP3+ T cells. Left: Absolute Treg counts for individual patients. Right: Mean ratio Treg count/baseline ± SEM for each cohort. (C) CYT107 administration does not affect long-term expression of CD127 on CD4+ or CD8+ T cells (data for individual patients shown).

Close Modal

or Create an Account

Close Modal
Close Modal